Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies-a case study of 14 patients in 11 families

Joint Bone Spine

Volumn 73, Issue 3, 2006, Pages 284-292

  Ladjouze Rezig, Aicha ^a   Rodriguez de Cordoba, Santiago ^b   Aquaron, Robert ^c  

^a Ben Aknoun Hospital   (Algeria)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^c Ctr de Biochim et de Biol Molec   (France)

Author keywords

Alkaptonuria; Homogentisate 1,2 dioxygenase; Homogentisic acid; Ochronosis; Ochronotic arthropathy

Indexed keywords

ADULT; AGED; ALKAPTONURIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST; FAMILY; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENOMICS; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; MOLECULAR DYNAMICS; PHENOTYPE; STOP CODON;

ADOLESCENT; ADULT; AGED; ALKAPTONURIA; DNA; FEMALE; GENETIC SCREENING; GENOTYPE; HOMOGENTISATE 1,2-DIOXYGENASE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RHEUMATIC DISEASES;

EID: 33646054545     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2005.03.010     Document Type: Article

References (58)

1. Garrod A.E. About alkaptonuria. Lancet 2 (1901) 1484
2. Garrod A.E. The incidence of alkaptonuria: a study in clinical individuality. Lancet 2 (1902) 1616-1620
3. Garrod A.E. The croonian lectures on inborn errors of metabolism, lecture II: alkaptonuria. Lancet 2 (1908) 73-79
4. La Du B.N., Zannoni V.G., Laster L., and Seegmiller J.E. The nature of the defect in tyrosine metabolism in alkaptonuria. J. Biol. Chem. 230 (1958) 251-260
5. Fernandez-Cannon J.M., and Penalva M.A. Molecular characterization of a gene encoding a homogentisate dioxygenase from Aspergillus nidulans and identification of its human and plant homologues. J. Biol. Chem. 270 (1995) 21199-21205
6. Fernandez-Canon J.M., Granadino B., Beltran-Valero de Bernabé D., Renedo M., Fernandez-Ruiz E., Penalva M.A., et al. The molecular basis of alkaptonuria. Nat. Genet. 14 (1996) 19-24
7. Hoodfar E., and Terbi A.S. Genetic referrals of middle eastern origin in a western city: inbreeding and disease profile. J. Med. Genet. 33 (1996) 212-215
8. De Peretti E., Bianchi M., and Clausse J. Étude clinique, biologique et génétique d'un cas d'alcaptonurie. Pediatrie 15 (1960) 211-215
9. Fauré C., and Parienty R. Le rhumatisme alcaptonurique. Ann. Radiol. (Paris) 4 (1961) 1037-1043
10. Crouzet J., Beraneck L., and Juan L.H. Rhumatisme alcaptonurique. une observation suivie pendant treize ans. Rev. Rhum. 59 (1992) 298-300
11. Desiré S. Alcaptonurie, ochronose et rhumatisme ochronotique. A propos de quinze observations dont treize cas nouveaux. Thèse de Médecine, Marseille, 1993.
12. Ladjouze A., Brahimi N., Guellati B., Lefkir S., Boussoussa A., Kara A., et al. Association d'un rhumatisme alcaptonurique sévère et d'une goutte tophacée: à propos d'une observation. Rev. Rhum. 65 (1998) 755
13. Ladjouze-Rezig A., Brahimi N., Kara A., Halit A., Mahiddine N., Guelib F., et al. Rhumatisme alcaptonurique: une affection souvent méconnue. Rev. Rhum. 68 (2001) 982
14. Martin E., Milhaud G., Courvoisier B., and Lapiné A. Étude de deux cas d'alcaptonurie. Bull. Soc. Med. Hop. Paris 66 (1950) 1050-1054
15. Aubert L., Detolle P., Sudaka P., Paecht A., and Esteve J. Deux cas d'alcaptonurie. Mars. Med. 102 (1965) 537-540
16. Paget M., and Valdiguié P. Contribution à l'étude de l'alcaptone et de l'alcaptonurie. Bull. Soc. Chim. Biol. (Paris) 23 (1941) 1508-1514
17. Vaccon L., Masbernard A., Hugny D., Cenac A., and Meunier J. L'alcaptonurie. Bull. Soc. Med. Chir. Hop. Arm. 5 (1970) 379-392
18. Hogben R.L., Worral R.L., and Zieve I. The genetic basis of alkaptonuria. Proc. R. Soc. Edinb. 52 (1932) 264-295 (biol)
19. O'Brien W.M., La Du B.N., and Bunim J.J. Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy. Review of world literature (1584-1962). Am. J. Med. 34 (1963) 813-837
20. Srsen S. Alkaptonuria. Johns Hopkins Med. J. 145 (1979) 217-226
21. Cooper J.A., and Moran T.J. Studies on ochronosis. Report of case with death from ochronotic nephrosis. Arch. Pathol. 64 (1957) 46-53
22. Nuri S.R. Prostatic and renal stones and unilateral obstruction of the urinary tract caused by ochronosis. Am. J. Roent. 158 (1992) 214-215
23. Venkataseshan V.S., Chandra B., Graziano V., Steinlauf P., Marquet E., Irmiere V., et al. Alkaptonuria and renal failure: a case report and review of the literature. Mod. Pathol. 5 (1992) 464-471
24. Zibolen M., Srsnova K., and Srsen S. Increased urolithiasis in patients with alkaptonuria in childhood. Clin. Genet. 25 (2000) 79-80
25. Introne W.J., Phornphutkul C., Bernardini I., McLaughlin K., Fitzpatrick D.L., and Gahl W.A. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation. Mol. Genet. Metab. 77 (2002) 136-142
26. Leslie A. Alkaptonuria with hyperuricemia. Arch. Intern. Med. 71 (1943) 68-77
27. David-Chaussé J., and Dehais J. Forme historique d'ochronose alcaptonurique associée à une goutte tophacée. Bull. Soc. Franc. Derm. 75 (1968) 107
28. David-Chaussé J., Dehais J., Bullier R., and De Verdelhan des Molles J. Quatre cas d'ochronose alcaptonurique. Rhumatologie 30 (1978) 5-17
29. Khachadurian A., and Abu Feisal K. Alkaptonuria: report of a family with seven cases appearing in four successive generations with metabolic studies in one patient. J. Chronic. Dis. 7 (1958) 455-465
30. DeSilva A.P., Seneviratne S.L., Gunatilake S.B., Fonseka M., Jayasekera R., and DeSilva H.J. A family with alkaptonuria showing quasi dominant inheritance. Ceylan. Med. J. 44 (1999) 130-132
31. Pieter H. Une famille d'alcaptonuriques. Presse Med. 33 (1925) 1310
32. Milch R.A., and Milch H. Dominant inheritance of alcaptonuria. Acta. Genet. 7 (1957) 178-184 (Basel)
33. Milch R.A. Studies of alcaptonuria: inheritance of 47 cases in eight highly inter-related dominican kindreds. Am. J. Hum. Genet. 12 (1960) 76-85
34. Pollak M.R., Chou Y.H., Cerda J.J., Steinmann B., La Du B.N., Seidman J.G., et al. Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2. Nat. Genet. 14 (1993) 201-204
35. Janocha S., Wolz W., Srsen S., Srsnova K., Montagutelli X., Guenet J.L., et al. The human gene for alkaptonuria (AKU) maps to chromosome 3q. Genomics 19 (1994) 5-8
36. Granadino B., Beltran-Valero de Bernabé D., Fernandez-Canon J.M., Penalva M.A., and Rodriguez de Cordoba S. The human homogentisate 1,2-dioxygenase (HGO) gene. Genomics 43 (1997) 115-122
37. Gehrig A., Schmidt S.R., Muller C.R., Srsen S., Srsnova K., and Kress W. Molecular defects in alkaptonuria. Cytogenet. Cell. Genet. 76 (1997) 14-16
38. Higashino K., Liu W., Ohkawa T., Yamamoto T., Fukui K., Ohno M., et al. A novel point mutation associated with alkaptonuria. Clin. Genet. 53 (1998) 228-229
39. Ramos S.M., Hernandez M., Roces A., Larruga J.M., Gonzalez P., Gonzalez A.M., et al. Molecular diagnosis of alkaptonuria mutation by analysis of homogentisate 1,2-dioxygenase mRNA from urine and blood. Am. J. Med. Genet. 78 (1998) 192-194
40. Beltran-Valero de Barnabé D., Granadino B., Chiarelli I., Porfirio B., Mayatepek E., Aquaron R., et al. Mutation and polymorphism of the human homogentisate 1,2-dioxygenase gene in alkaptonuria patients. Am. J. Hum. Genet. 62 (1998) 776-784
41. Beltran-Valero de Bernabé D., Jimenez F.J., Aquaron R., and Rodriguez de Cordoba S.R. Analysis of alkaptonuria (AKU) mutations and polymorphisms reveals that the CCC sequence motif is a mutational hot spot in the homogentisate 1,2-dioxygenase gene (HGO). Am. J. Hum. Genet. 64 (1999) 1316-1322
42. Beltran-Valero de Barnabé D., Petreson P., Luopajarvi L.K., Matintalo P., Alho A., Konttinen Y., et al. Mutational analysis of the HGO gene in Finnish alkaptonuria patients. J. Med. Genet. 36 (1999) 922-923
43. Muller C.R., Fregin A., Srsen S., Srsnova K., Halliger-Keller B., Felbor U., et al. Allelic heterogeneity of alkaptonuria in central Europe. Eur. J. Hum. Genet. 7 (1999) 645-651
44. Walter K., Gaa A., Schaefer H.E., and Roers A. Sequence analysis of the homogentisate 1,2-dioxygenase gene in a family affected by alkaptonuria. J. Med. Genet. 36 (1999) 645-646
45. Felbor U., Mutsch Y., Grehn F., Muller C.R., and Kress W. Ocular ochronosis in alkaptonuria patients carrying mutations in the homogentisate 1,2-dioxygenase gene. Br. J. Ophthalmol. 83 (1999) 680-683
46. Porfirio B., Chiarelli I., Graziano C., Mannoni A., Morrone A., Zammarchi E., et al. Alkaptonuria in Italy: polymorphic haplotype background, mutational profile and description of four novel mutations in the homogentisate 1,2-dioxygenase gene. J. Med. Genet. 37 (2000) 309-312
47. Zatkova A., Polakova H., Micutkova H., Zvarik M., Bosak V., Ferakova E., et al. Novel mutations in homogentisate 1,2-dioxygenase gene identified in Slovak patients with alkaptonuria. J. Med. Genet. 37 (2000) 539-542
48. Zatkova A., Beltran Valero de Bernabé D., Polakova H., Zvarik M., Ferakova E., Bosak V., et al. High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiples mutations in HGO involving different mutational hot spots. Am. J. Hum. Genet. 67 (2000) 1333-1339
49. Phornphutkul C., Introne W.J., Perry M.B., Bernardini I., Murphey M.D., Fitzpatrick D.L., et al. Natural history of alkaptonuria. N. Engl. J. Med. 347 (2002) 2111-2121
50. Goicoechea de Jorge E., Lorda I., Gallardo M.E., Perez B., Perez de Ferran C., Mendoza H., et al. Alkaptonuria in the Dominican Republic: identification of the founder AKU mutation and further evidence of mutation hot spots in the HGO gene. J. Med. Genet. 39 (2002) e40
51. Uyguner O., Goicoechea de Jorge E., Cefle A., Baykal T., Kayserili H., Demirkol M., et al. Molecular analysis of the HGO gene mutations in Turkish alkaptonuria patients suggest that the R58fs mutation originated from central Asia and was spread throughout Europe and Anatolia by human migrations. J. Inherit. Metab. Dis. 26 (2003) 17-23
52. Mannoni A., Selvi E., Lorenzini S., Giorgi M., Airo P., Cammelli D., et al. Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin. Arthritis Rheum. 33 (2004) 239-248
53. Rodriguez J.M., Timm D.E., Titus G.P., Beltran-Valero de Bernabé D., Criado O., Mueller H.A., et al. Structural and functional analysis of mutations in alkaptonuria. Hum. Mol. Genet. 9 (2000) 2341-2350
54. Vaillant L., Estève E., Vidal S., Barruet K., Goupille P., and Lorette G. Pigmentation des oreilles, escarres et atteinte rhumatismale: ochronose alcaptonurique. Ann. Dermatol. Venereol. 120 (1993) 753-755
55. Cartegni L., Chew S.L., and Krainer A.R. Listening to silence and understanding non sense exonic mutations that affect splicing. Nat. Genet. 3 (2002) 285-298
56. Fernandez-Cadenas I., Andreu A.L., Gamez G., Gonzalo R., Martin M.A., Rubio J.C., et al. Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease. Neurology 61 (2003) 1432-1434
57. Dermot K., Ptacin M.J., Bamrah V.S., and Almagro U. Cardiovascular ochronosis: a case report and review of the medical literature. Cardiology 77 (1990) 477-483
58. Ferchiou A., Castaing H., and Khadraoui S. L'alcaptonurie: à propos d'un cas reconnu dès la naissance. Tunis. Med. 48 (1970) 397-399